Search Results - "Chekhun, Sviatoslav"
-
1
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Published in Exploration of targeted anti-tumor therapy (2023)“…Third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown impressive results in mutant lung cancer (LC) patients in…”
Get full text
Journal Article -
2
A Risk Score for Single-Lumen Peripherally Inserted Central Catheter (PICC)-Related Venous Thrombosis in Cancer Patients Undergoing Ambulatory Chemotherapy
Published in Blood (15-11-2022)Get full text
Journal Article -
3
Effect of high immune-related gene expression on resistance to CDK4/6 inhibitors in advanced breast cancer
Published in Journal of clinical oncology (01-06-2023)“…e13063 Background: Treatment for estrogen receptor-positive (ER+)/HER2-negative advanced breast cancer (ABC) has undergone a revolution with the approval of…”
Get full text
Journal Article -
4
Is IDO1 an adequate target for treatment in glioblastoma?
Published in Journal of clinical oncology (01-06-2022)“…e14039 Background: Glioblastoma (GB) is the most prevalent primary brain tumor in adults. The first-line treatment is based on standard brain surgery and…”
Get full text
Journal Article -
5
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Published in Exploration of targeted anti-tumor therapy (01-01-2023)“…Third-generation epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown impressive results in EGFR mutant lung cancer (LC)…”
Get full text
Report